Vaxart (NASDAQ:VXRT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Vaxart (VXRT) operate in?

Vaxart is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Vaxart Stock (NASDAQ: VXRT) stock price, news, charts, stock research, profile.

Open	$0.68
Close	$0.68
Volume / Avg.	1.82M / 4.07M
Day Range	0.66 - 0.69
52 Wk Range	0.52 - 1.54
Market Cap	$118.88M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	7.91%
Days to Cover	1.27

Recent News

$1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buying

Avi Kapoor

Vaxart Stock Is Moving Higher After The Bell: What's Going On?

Vaxart, a clinical-stage biotechnology company developing a range of oral recombinant vaccines, announced Monday that proceeds from a recent offering combined with reimbursements under its Project NextGen award are expected to extend the company's cash runway into 2026.

Adam Eckert

Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering

Vaxart (VXRT) shares surged 23% in premarket session after receiving a $453 million project award from BARDA to conduct a COVID-19 vaccine study.

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Vaxart Inc

Sector

Health Care

Industry

Biotechnology

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombin...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vaxart (VXRT) stock?

You can purchase shares of Vaxart (NASDAQ:VXRT) through any online brokerage.

View our list of the best stock brokerages

Who are Vaxart (VXRT) competitors?

Other companies in Vaxart’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Armata Pharmaceuticals (AMEX:ARMP), FibroGen (NASDAQ:FGEN), Vistagen Therapeutics (NASDAQ:VTGN) and Tevogen Bio Holdings (NASDAQ:TVGN).

What is the target price for Vaxart (VXRT) stock?

There is no analysis for Vaxart.

What is the forecast for Vaxart (VXRT) stock?

Vaxart has a consensus price target of $3.00.

Current stock price for Vaxart (VXRT)?

The stock price for Vaxart (NASDAQ: VXRT) is $0.67 last updated July 15, 2024 at 7:29 PM EDT.

Does Vaxart (VXRT) pay a dividend?

There are no upcoming dividends for Vaxart.

When is Vaxart (NASDAQ:VXRT) reporting earnings?

Vaxart’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Is Vaxart (VXRT) going to split?

There is no upcoming split for Vaxart.

What sector and industry does Vaxart (VXRT) operate in?

Vaxart is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Vaxart

Vaxart (VXRT) Forecast